{"id":1093551,"date":"2023-01-06T16:11:00","date_gmt":"2023-01-06T21:11:00","guid":{"rendered":"https:\/\/www.prime-wow.com\/?p=1093551"},"modified":"2023-01-06T16:11:00","modified_gmt":"2023-01-06T21:11:00","slug":"fda-approves-new-alzheimers-drug-but-there-are-lingering-questions","status":"publish","type":"post","link":"https:\/\/www.prime-wow.com\/?p=1093551","title":{"rendered":"FDA Approves New Alzheimer&#039;s Drug, but There Are Lingering Questions"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.prime-wow.com\/wp-content\/uploads\/2023\/01\/d2462c7b0d1aa2494259fa7c0bb80050.jpg\" \/><\/p>\n<p>The Food and Drug Administration on Friday granted the conditional approval of a new treatment for people with early Alzheimer\u2019s disease: the antibody-based drug lecanemab, jointly developed by the pharmaceutical companies Biogen and Eisai. In a large trial, lecanemab appeared to slow down patients\u2019 cognitive decline\u2026<\/p>\n<p><a href=\"https:\/\/gizmodo.com\/fda-approves-lecanemab-alzheimers-drug-1849960507\">Read more&#8230;<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nSource: Gizmodo &#8211; <a href=\"https:\/\/gizmodo.com\/fda-approves-lecanemab-alzheimers-drug-1849960507\" target=\"_blank\" rel=\"noopener\">FDA Approves New Alzheimer&#8217;s Drug, but There Are Lingering Questions<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Food and Drug Administration on Friday granted the conditional approval of a new treatment for people with early Alzheimer\u2019s disease: the antibody-based drug lecanemab, jointly developed by the pharmaceutical companies Biogen and Eisai. In a large trial, lecanemab appeared &hellip; <a href=\"https:\/\/www.prime-wow.com\/?p=1093551\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1093552,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[105,110],"tags":[104],"class_list":["post-1093551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gizmodo","category-unfiltered-rss","tag-gizmodo"],"_links":{"self":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1093551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1093551"}],"version-history":[{"count":0,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1093551\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/media\/1093552"}],"wp:attachment":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1093551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1093551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1093551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}